2018 Annual MarkVCID Conference

MarkVCID Group

MarkVCID 2018 Annual Conference Attendees
January 22-23, 2018

Preceding the AHA International Stroke Conference, the MarkVCID Consortium held its second annual conference at the University of Southern California Keck School of Medicine. Nearly 100 contributors joined from research sites nationwide to discuss the development of candidate biomarkers and treatments for vascular cognitive impairment. [Read USC’s article]


Rush University &
Illinois Institute of Technology
Julie Schneider, MD, MS
Konstantinos Arfanakis, PhD
University of Kentucky
Donna Wilcock, PhD; Greg Jicha, MD, PhD
Brian Gold, PhD; Omar Al-Janabi, MD
& Ahmed Bahrani
University of Southern California
Danny Wang, PhD, MSCE
Amir Kashani, MD, PhD
Biomarker Validation
Eric Smith, MD, MPH
Hotchkiss Brain Institute, Uni. of Calgary
University of California
San Francisco, Davis & Los Angeles
Joel Kramer, PsyD; Charles DeCarli, MD
& Jason Hinman, MD
STARDdem Reporting Standards
Lon Schneider, MD, MS
Keck School of Medicine, USC
Johns Hopkins Medical Center
Hanzhang Lu, PhD; Marylin Albert, PhD &
Sandeepa Sur, PhD
UH3 Data Management
Karl Helmer, PhD & Alex Sherman
Coordinating Center
University of New Mexico
Gary Rosenberg, MD; Arvind Caprihan, PhD
& Vince Calhoun, PhD
UH3 Subject Procedures
Deborah Blacker, MD, ScD; Konstantinos
Arfanakis, PhD; Donna Wilcock, PhD
CHARGE Consortium
Sudha Seshadri, MD; Myriam Fornage, PhD
& Russell Tracy, PhD

Dr. DeCarli, UCD


Dr. Seshadri, CHARGE


Dr. Lu, JHU


Dr. Schneider, Rush


Dr. Wang, USC


Dr. Wilcock, UKY


Dr. Caprihan, UNM


Dr. Greenberg, MGH

Copyright © 2017. All rights reserved.